600+ sources. One page. See who else covered it.
Journalists can apply for AHF Nigeria’s two-month HIV and TB media reporting project to promote ethical, solutions-focused reporting on these diseases. Read More: https://punchng.com/ahf-unveils-hiv-tb-media-reporting-project-for-journalists/
We haven't written up this one. Punch Nigeria has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Silence Therapeutics is set to advance its siRNA drug for the rare blood disorder polycythemia vera (PV) into Phase 3 following a successful mid-stage trial.
A rare blood cancer drug from Silence Therapeutics showed strong results in a trial, potentially setting it up to compete with a Takeda medicine.
Ticks are especially abundant this summer. However, there are several ways to mitigate the risks associated with them, says Tiina Elvisto, associate professor of plant ecology at Tallinn University.
A Tenax Therapeutics drug designed to treat a type of heart failure associated with high blood pressure in the lungs failed in a closely watched study.
Nigeria’s healthcare sector needs more than additional funding to expand. The post FCMB, Healthcare Stakeholders Set Out Roadmap to Move Nigeria’s Health Sector from Survival to Scale appeared first…
The supermarket chain has initiated a new recall of frozen blueberries and mixed berries as a CDC outbreak investigation continues. Here’s the latest.